Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$2.72
-0.91%
Mkt Cap $446.77M
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+501.5%
Consensus $16.33 vs current $2.72
NASDAQ·Healthcare·Biotechnology
$2.72
-0.91%
Mkt Cap $446.77M
Buy
4
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+501.5%
Consensus $16.33 vs current $2.72